The single standard treatment for Trichomonas vaginalis is in question

Published on 04/02/2020

A recently published paper issues a challenge to the health and scientific community.

“Despite drug resistance being documented for decades, 5-Nitroimidazoles remain the only treatment option"
“Trichomoniasis is the most common, non-viral sexually transmitted infection worldwide, accounting for Quarter billion cases each year”

Read more at Biomed's page on T. vaginalis and STD Awareness ►

Published in the following categories: CDC STI Clinical Trich WHO